戻る Agenda
LS40 Promoting DX (Digital Transformation) in Risk Communication to Patients
Session Chair(s)
Kazuhiko Ishida, MSC, RPH
Director, Pharmacovigilance, Astellas Pharma Inc., Japan
Speaker(s)
Michiko Yamamoto, PHD
Pharmaceutical Sciences/Visiting Professor, Graduate School of Kumamoto University, Japan
Shinya Takemoto, MSC
Group Manager, Safety Information Strategy Group, Risk Communication Department, Chugai Pharmaceutical Co., Ltd., Japan
